We are live on ! Find out more
JA

JLB & Associates Portfolio holdings

AUM $696M
1-Year Est. Return 17.86%
This Fund
S&P 500
This Quarter Est. Return
+2.93%
1 Year Est. Return
+17.86%
3 Year Est. Return
+57.72%
5 Year Est. Return
+93.63%
10 Year Est. Return
–
AUM
$470M
AUM Growth
+$5.16M
Cap. Flow
-$4.49M
Cap. Flow %
-0.96%
Top 10 Hldgs %
34.1%
Holding
71
New
2
Increased
32
Reduced
28
Closed
2

Top Buys

1
DEO icon
Diageo
DEO
+$6.29M
2
MRSH
Marsh
MRSH
+$6.06M
3
UNH icon
UnitedHealth
UNH
+$1.76M
4
AMGN icon
Amgen
AMGN
+$1.16M
5
EXPD icon
Expeditors International
EXPD
+$1.14M

Top Sells

1
KDP icon
Keurig Dr Pepper
KDP
+$14.5M
2
GILD icon
Gilead Sciences
GILD
+$7.53M
3
COL
Rockwell Collins
COL
+$1.06M
4
MA icon
Mastercard
MA
+$786K
5
CPRT icon
Copart
CPRT
+$614K

Sector Composition

1 Industrials 20.79%
2 Consumer Discretionary 20.25%
3 Technology 18.27%
4 Financials 12.83%
5 Consumer Staples 10.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AME icon
26
Ametek
AME
$54.3B
$8.8M 1.87%
121,935
-2,456
-2% -$182K
PII icon
27
Polaris
PII
$4.16B
$8.46M 1.8%
69,276
+2,411
+4% +$282K
CBRL icon
28
Cracker Barrel
CBRL
$1.2B
$8.42M 1.79%
53,915
-789
-1% -$127K
NVO
29
Novo Nordisk
NVO
$223B
$7.52M 1.6%
326,050
+35,610
+12% +$846K
DEO icon
30
Diageo
DEO
$46.7B
$7.29M 1.55%
50,608
+43,933
+658% +$6.29M
SYK icon
31
Stryker
SYK
$123B
$7.09M 1.51%
42,007
+215
+0.5% +$36.2K
CNI icon
32
Canadian National Railway
CNI
$78.3B
$7.08M 1.51%
86,610
+707
+0.8% +$56.2K
ORLY icon
33
O'Reilly Automotive
ORLY
$71.3B
$6.95M 1.48%
380,835
+3,525
+0.9% +$61.4K
MRSH
34
Marsh
MRSH
$87.8B
$6.55M 1.39%
79,916
+74,196
+1,297% +$6.06M
DLTR icon
35
Dollar Tree
DLTR
$24.2B
$6.31M 1.34%
74,285
-254
-0.3% -$23.4K
ABBV icon
36
AbbVie
ABBV
$450B
$6.27M 1.33%
67,662
-290
-0.4% -$28.3K
SLGN icon
37
Silgan Holdings
SLGN
$4.99B
$5.39M 1.15%
201,052
-189
-0.1% -$5.19K
EXPD icon
38
Expeditors International
EXPD
$23.9B
$5.04M 1.07%
68,882
+16,273
+31% +$1.14M
LEA icon
39
Lear
LEA
$7.1B
$4.92M 1.05%
26,501
+1,359
+5% +$266K
K
40
DELISTED
Kellanova
K
$3.98M 0.85%
60,720
-1,544
-2% -$91.8K
HSIC icon
41
Henry Schein
HSIC
$10B
$3.98M 0.85%
69,828
+68
+0.1% +$3.83K
RTN
42
DELISTED
Raytheon Company
RTN
$3.69M 0.79%
19,123
+90
+0.5% +$18.9K
LH icon
43
Labcorp
LH
$23.2B
$3.34M 0.71%
21,664
-1,019
-4% -$154K
RHI icon
44
Robert Half
RHI
$4.28B
$2.71M 0.58%
41,604
+996
+2% +$63.2K
FDS icon
45
Factset
FDS
$9.18B
$2.63M 0.56%
13,281
+74
+0.6% +$14.8K
LLY icon
46
Eli Lilly
LLY
$1.05T
$2.41M 0.51%
28,219
– –
SHW icon
47
Sherwin-Williams
SHW
$81.7B
$2.34M 0.5%
17,223
+2,175
+14% +$281K
KMB icon
48
Kimberly-Clark
KMB
$36B
$2.31M 0.49%
21,892
– –
ALK icon
49
Alaska Air
ALK
$5.07B
$2.26M 0.48%
37,369
-671
-2% -$41.5K
MTD icon
50
Mettler-Toledo International
MTD
$26.5B
$1.95M 0.41%
3,363
– –
1
2
3

Similar funds

AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
CA
Cortland Associates St Louis, Missouri $697M AUM 4.23% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
FCM
Fourpath Capital Management Oklahoma City, Oklahoma $697M AUM 29.98% 1-Year Est. Return
GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
AWC
Abundance Wealth Counselors State College, Pennsylvania $697M AUM 23.83% 1-Year Est. Return
BBPWM
Blue Bell Private Wealth Management Blue Bell, Pennsylvania $696M AUM 17.73% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

JLB & Associates's Q2 2018 Portfolio in Review

As of Q2 2018, JLB & Associates held 71 positions worth $470M, up 1.1% from $465M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

JLB & Associates's Q2 2018 filing shows 2 new, 32 increased, 28 reduced and 2 closed positions. Its largest new stake was UnitedHealth: 7,335 shares worth $1.8M. The largest sale was Keurig Dr Pepper, an estimated $14.5M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Technology.

  • JLB & Associates's largest Q2 2018 buy was UnitedHealth: 7,335 shares worth $1.8M.
  • JLB & Associates added most to Diageo in Q2 2018, an estimated $6.29M increase.
  • JLB & Associates's biggest Q2 2018 reduction was Gilead Sciences, cutting an estimated $7.53M.
  • JLB & Associates fully exited Keurig Dr Pepper in Q2 2018, selling an estimated $14.5M.
  • JLB & Associates's ten largest holdings make up 34% of its $470M portfolio in Q2 2018.
  • JLB & Associates opened 2 new positions and closed 2 in Q2 2018.
  • JLB & Associates's portfolio value rose 1.1% quarter-over-quarter to $470M.

Based on JLB & Associates's 13F filing for Q2 2018, filed 9 Jul 2018.